Chronic News and Research

RSS

Legal Cannabis hemp oil helps reduce chronic neuropathic pain in mice

Researchers examine the effectiveness of consuming hemp oil extracted from the whole Cannabis plant using a chronic neuropathic pain animal model.

20 May 2020

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. T

20 May 2020

Doctoral candidate receives NIH fellowship to study how adenovirus affects heart function

A dose of adenovirus hits most people like a common cold - a cough, a fever, maybe a sore throat. But for an unfortunate few, the usually benign bug hacks the heart's cellular electrical communication system and sometimes proves fatal.

20 May 2020

Family environment and socioeconomic status affect brain development during adolescence

Childhood environment and socioeconomic status affect cognitive ability and brain development during adolescence independently of genetic factors, researchers at Karolinska Institutet report in a new study published in the journal PNAS.

20 May 2020

New technique determines lipid composition in a brain region

Researchers at the Beckman Institute at the University of Illinois at Urbana-Champaign have developed a new technique that can determine the specific molecular form, location, and the number of lipids in samples of rat brain tissue.

20 May 2020

New study may eliminate dangerous side effects of drugs used for treating various conditions

Psychedelics such as LSD and magic mushrooms have proven highly effective in treating depression and post-traumatic stress disorders, but medical use of these drugs is limited by the hallucinations they cause.

20 May 2020

Does COVID-19 infect peripheral blood cells?

The emergence of the novel coronavirus outbreak in December 2019 was followed by its spread on a global scale unparalleled in the last 100 years. At present, it has claimed over 322,000 lives the world over, with over 4.88 million cases having tested positive.

19 May 2020

Sleep apnea may increase the risk of severe COVID-19, say researchers

An analysis conducted by researchers at the University of Turku and Turku University Hospital in Finland has suggested that obstructive sleep apnea (OSA) may be a risk factor for severe coronavirus disease 2019 (COVID-2019).

19 May 2020

DZD researchers discover additional genetic cause for non-alcoholic fatty liver disease

In Germany about 18 million people suffer from non-alcoholic fatty liver. The causes of this disease are manifold and include environmental as well as genetic factors.

19 May 2020

A minimally invasive approach to managing pain without opioids

Researchers at the University of Wisconsin (UW) are adopting a minimally invasive, safer approach to electrically treating pain directly at the source as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative.

19 May 2020

People with Hepatitis D have up to three times the risk of developing fatal liver cancer

Of all the hepatitis viruses, D is the most poorly known. This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.

18 May 2020

Potential new treatment approach to fatal COVID-19

Researchers from the University of Colorado Anschutz Medical Campus and Pathways Bioscience in the United States have found that activating a transcription factor involved in oxidative stress regulation, antiviral activity, and inflammation may serve as a new treatment approach to coronavirus disease 2019 (COVID-19).

18 May 2020

Fibroblasts of different pancreatic diseases exhibit distinct properties, study reveals

Fibroblasts present in different pancreatic diseases are genetically distinct and their functions are 'programmed' by the unique environment of each disease, according to new research from the University of Liverpool (UK).

18 May 2020

Drugmakers tout COVID-19 vaccines to refurbish their public image

Johnson & Johnson researchers working on a vaccine against the coronavirus are "just like the heroes in the hospitals" fighting to save patients, J&J CEO Alex Gorsky said on the "Today" show a few weeks ago.

18 May 2020

People infected with hepatitis D are more prone to hepatocellular carcinoma

Of all the hepatitis viruses, D is the most poorly known.This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.

18 May 2020

Research explores how human enzymes could be used to exacerbate COVID-19

Centenary Institute researchers have examined the critical role of human enzymes and the coronavirus in a newly published scientific review article that explores potential strategies for COVID-19 disease treatment and management.

18 May 2020

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda Pharmaceutical Company Limited today announced that the company will present data from its expanding oncology pipeline and established product portfolio at two upcoming virtual scientific congresses: the 56th Annual Meeting of the American Society of Clinical Oncology, May 29-31 and the 25th Virtual Congress of the European Hematology Association, June 11-14.

18 May 2020

Sociodemographic factors linked to positive SARS-CoV-2 test result in primary care

Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.

15 May 2020

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

The Networks of Centres of Excellence recently announced its continued support in Canadian glycomics research with a three-year investment of $16.3 million through the Canadian Glycomics Network (GlycoNet).

15 May 2020

Mcmaster researchers develop new blood test to track individual fat intake

A team of researchers at McMaster University has developed a reliable and accurate blood test to track individual fat intake, a tool that could guide public health policy on healthy eating.

15 May 2020

Chronic News and Research

Legal Cannabis hemp oil helps reduce chronic neuropathic pain in mice

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Doctoral candidate receives NIH fellowship to study how adenovirus affects heart function

Family environment and socioeconomic status affect brain development during adolescence

New technique determines lipid composition in a brain region

New study may eliminate dangerous side effects of drugs used for treating various conditions

Does COVID-19 infect peripheral blood cells?

Sleep apnea may increase the risk of severe COVID-19, say researchers

DZD researchers discover additional genetic cause for non-alcoholic fatty liver disease

A minimally invasive approach to managing pain without opioids

People with Hepatitis D have up to three times the risk of developing fatal liver cancer

Potential new treatment approach to fatal COVID-19

Fibroblasts of different pancreatic diseases exhibit distinct properties, study reveals

Drugmakers tout COVID-19 vaccines to refurbish their public image

People infected with hepatitis D are more prone to hepatocellular carcinoma

Research explores how human enzymes could be used to exacerbate COVID-19

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Sociodemographic factors linked to positive SARS-CoV-2 test result in primary care

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

Mcmaster researchers develop new blood test to track individual fat intake

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News